Condition (MeSH)
Paget's Disease, Mammary
ClinicalTrials.gov lists 2 trials for Paget's Disease, Mammary or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 2 trials are tagged with Paget's Disease, Mammary itself; the rest are tagged with a narrower condition beneath it.
When did Paget's Disease, Mammary trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2013 | 1 |
| 1997 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Paget's Disease, Mammary trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
How many Paget's Disease, Mammary trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Paget's Disease, Mammary trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Cancer Institute (NCI) | 1 |
| SWOG Cancer Research Network | 1 |
Which publications cover Paget's Disease, Mammary? (2)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Comparative study of breast cancer with or without concomitant Paget disease: An analysis of the SEER database. | Cancer medicine | 2019 | Yes |
| Centennial paper. May 1912 (J Cutan Dis Syph 1912;30:241-255). Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. By John T. Bowen, M.D., Boston. | Archives of dermatology | 1983 | No |
Prevalence (48)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Paget disease of the nipple | Annual incidence | 1-9 / 1 000 000 | United Kingdom | GB | Exact |
| Paget disease of the nipple | Annual incidence | 1-9 / 1 000 000 | United Kingdom | GB | Exact |
| Paget disease of the nipple | Annual incidence | 1-9 / 1 000 000 | Iceland | Not stated | Exact |
| Paget disease of the nipple | Annual incidence | 1-9 / 1 000 000 | Lithuania | Not stated | Exact |
| Paget disease of the nipple | Annual incidence | 1-9 / 1 000 000 | Croatia | Not stated | Exact |
Showing 5 of 48 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Paget disease of the nipple | 180275 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Paget disease of the nipple | 180275 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.